KeyBank National Association’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.76M | Buy |
57,588
+3,606
| +7% | +$155K | 0.01% | 415 |
|
|
2026
Q1 | $1.98M | Buy |
53,982
+3,771
| +8% | +$179K | 0.01% | 459 |
|
|
2025
Q4 | $2.55M | Sell |
50,211
-6,806
| -12% | -$348K | 0.01% | 397 |
|
|
2025
Q3 | $3.16M | Sell |
57,017
-1,307
| -2% | -$76.5K | 0.01% | 353 |
|
|
2025
Q2 | $4.03M | Sell |
58,324
-1,451
| -2% | -$98.7K | 0.02% | 318 |
|
|
2025
Q1 | $4.15M | Sell |
59,775
-6,722
| -10% | -$555K | 0.02% | 306 |
|
|
2024
Q4 | $5.72M | Buy |
66,497
+1,007
| +2% | +$109K | 0.02% | 271 |
|
|
2024
Q3 | $7.8M | Buy |
65,490
+6,489
| +11% | +$865K | 0.03% | 253 |
|
|
2024
Q2 | $8.42M | Buy |
59,001
+1,357
| +2% | +$180K | 0.03% | 235 |
|
|
2024
Q1 | $7.4M | Sell |
57,644
-1,012
| -2% | -$120K | 0.03% | 244 |
|
|
2023
Q4 | $6.07M | Sell |
58,656
-712
| -1% | -$70.4K | 0.03% | 261 |
|
|
2023
Q3 | $5.4M | Buy |
59,368
+76
| +0.1% | +$6.7K | 0.03% | 260 |
|
|
2023
Q2 | $4.8M | Buy |
59,292
+400
| +0.7% | +$32.7K | 0.02% | 273 |
|
|
2023
Q1 | $4.69M | Buy |
58,892
+1,600
| +3% | +$113K | 0.02% | 269 |
|
|
2022
Q4 | $3.88M | Buy |
57,292
+2,270
| +4% | +$133K | 0.02% | 292 |
|
|
2022
Q3 | $2.74M | Buy |
55,022
+5,510
| +11% | +$295K | 0.01% | 315 |
|
|
2022
Q2 | $2.76M | Sell |
49,512
-1,406
| -3% | -$78K | 0.01% | 316 |
|
|
2022
Q1 | $2.83M | Sell |
50,918
-508
| -1% | -$26.1K | 0.01% | 331 |
|
|
2021
Q4 | $2.88M | Buy |
51,426
+1,402
| +3% | +$76K | 0.01% | 338 |
|
|
2021
Q3 | $2.4M | Buy |
50,024
+256
| +0.5% | +$12.4K | 0.01% | 355 |
|
|
2021
Q2 | $2.08M | Buy |
49,768
+1,528
| +3% | +$59.2K | 0.01% | 372 |
|
|
2021
Q1 | $1.63M | Buy |
48,240
+9,346
| +24% | +$333K | 0.01% | 413 |
|
|
2020
Q4 | $1.36M | Buy |
38,894
+8
| +0% | +$277 | 0.01% | 439 |
|
|
2020
Q3 | $1.35M | Buy |
38,886
+466
| +1% | +$15.5K | 0.01% | 406 |
|
|
2020
Q2 | $1.26M | Buy |
38,420
+10
| +0% | +$319 | 0.01% | 406 |
|
|
2020
Q1 | $1.16M | Sell |
38,410
-92
| -0.2% | -$2.74K | 0.01% | 389 |
|
|
2019
Q4 | $1.11M | Buy |
38,502
+8,612
| +29% | +$238K | 0.01% | 500 |
|
|
2019
Q3 | $773K | Sell |
29,890
-238
| -0.8% | -$6.02K | ﹤0.01% | 582 |
|
|
2019
Q2 | $769K | Buy |
30,128
+13,822
| +85% | +$342K | ﹤0.01% | 621 |
|
|
2019
Q1 | $426K | Buy |
16,306
+1,704
| +12% | +$41.9K | ﹤0.01% | 748 |
|
|
2018
Q4 | $336K | Sell |
14,602
-2,422
| -14% | -$53.8K | ﹤0.01% | 763 |
|
|
2018
Q3 | $401K | Buy |
17,024
+460
| +3% | +$11.2K | ﹤0.01% | 828 |
|
|
2018
Q2 | $382K | Hold |
16,564
| – | – | ﹤0.01% | 813 |
|
|
2018
Q1 | $408K | Sell |
16,564
-1,670
| -9% | -$43.8K | ﹤0.01% | 801 |
|
|
2017
Q4 | $489K | Buy |
18,234
+464
| +3% | +$11.8K | ﹤0.01% | 755 |
|
|
2017
Q3 | $428K | Buy |
17,770
+870
| +5% | +$19.7K | ﹤0.01% | 826 |
|
|
2017
Q2 | $362K | Sell |
16,900
-7,442
| -31% | -$150K | ﹤0.01% | 900 |
|
|
2017
Q1 | $417K | Sell |
24,342
-3,168
| -12% | -$55.2K | ﹤0.01% | 870 |
|
|
2016
Q4 | $493K | Sell |
27,510
-1,706
| -6% | -$30.9K | ﹤0.01% | 815 |
|
|
2016
Q3 | $608K | Sell |
29,216
-7,174
| -20% | -$178K | ﹤0.01% | 763 |
|
|
2016
Q2 | $979K | Sell |
36,390
-140
| -0.4% | -$3.84K | 0.01% | 558 |
|
|
2016
Q1 | $990K | Sell |
36,530
-51,050
| -58% | -$1.37M | 0.01% | 547 |
|
|
2015
Q4 | $2.54M | Sell |
87,580
-19,216
| -18% | -$532K | 0.02% | 310 |
|
|
2015
Q3 | $2.9M | Buy |
106,796
+8,286
| +8% | +$235K | 0.02% | 302 |
|
|
2015
Q2 | $2.7M | Buy |
98,510
+5,814
| +6% | +$163K | 0.02% | 326 |
|
|
2015
Q1 | $2.48M | Buy |
92,696
+5,188
| +6% | +$119K | 0.02% | 357 |
|
|
2014
Q4 | $1.85M | Buy |
87,508
+4,910
| +6% | +$110K | 0.01% | 422 |
|
|
2014
Q3 | $1.97M | Buy |
82,598
+8,422
| +11% | +$194K | 0.01% | 400 |
|
|
2014
Q2 | $1.71M | Buy |
74,176
+4,726
| +7% | +$104K | 0.01% | 467 |
|
|
2014
Q1 | $1.58M | Buy |
69,450
+6,750
| +11% | +$144K | 0.01% | 487 |
|
|
2013
Q4 | $1.16M | Buy |
62,700
+3,990
| +7% | +$69.5K | 0.01% | 596 |
|
|
2013
Q3 | $993K | Buy |
58,710
+4,760
| +9% | +$80.1K | 0.01% | 636 |
|
|
2013
Q2 | $836K | Buy |
+53,950
| New | +$898K | ﹤0.01% | 827 |
|
Other funds holding NVO
F
KeyBank National Association's NVO Position: Q2 2026 in Review
KeyBank National Association increased its Novo Nordisk (NVO) stake by 6.7% in Q2 2026, buying an estimated $155K and bringing the position to 57,588 shares worth $2.76M. The position accounts for 0.01% of the portfolio, ranked #415.
KeyBank National Association first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.42M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- KeyBank National Association held 57,588 shares of Novo Nordisk worth $2.76M as of Q2 2026.
- KeyBank National Association bought 3,606 Novo Nordisk shares in Q2 2026, an estimated $155K.
- Novo Nordisk made up 0.01% of KeyBank National Association's portfolio in Q2 2026, its #415 holding.
- KeyBank National Association first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's Novo Nordisk position peaked at $8.42M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.